Comparison of Different Antidepressants and Psychotherapy in the Short-term Treatment of Depression
|
|
- Bertha Logan
- 5 years ago
- Views:
Transcription
1 ORIGINAL COMPARISON PAPER OF DIFFERENT ANTIDEPRESSANTS AND PSYCHOTHERAPY IN THE SHORT-TERM TREATMENT OF DEPRESSION Comparison of Different Antidepressants and Psychotherapy in the Short-term Treatment of Depression Azhar MZ, Noorjan KON, Zubaidah JO Department of Psychiatry, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia. This paper reports the result of an analysis of data of brief therapy for patients with depression referred by physicians in a busy specialist hospital in Kuala Lumpur. The patients were divided into three groups at random using one of three antidepressants i.e. escitalopram, sertraline, or fluoxetine. All patients received cognitive behavior therapy. The therapy was aimed for a maximum of twelve sessions after which the patients will be discharged. However there were patients on escitalopram and sertraline that went on follow-up sessions monthly till six months and these patients were analized separately. There were 32 patients in the escitalopram group, 33 patients in the sertraline group, and 31 patients in the fluoxetine group. The result shows that all the groups were similar in the severity and scores pre-treatment but post-treatment there were a significant difference among them. All groups showed significant improvements in all modalities of measurements. However the escitalopram group showed better improvement compared to the two other groups. Key words: Depression, antidepressants, cognitive behaviour therapy, psychotherapy Malaysian Journal of Psychiatry September 2007, Vol. 16, No. 2 Introduction Antidepressants have been used for many years to treat depression with significant success. The most used group of antidepressants is the specific serotonin reuptake inhibitor (SSRI). All the three drugs used in this study i.e. escitalopram (ESC), sertraline (STR), and fluoxetine (FXT) are SSRIs. They have all been shown to be very effective in the treatment of major depressive disorders with ESC being the youngest of the three to be used in Malaysia. Cognitive behaviour therapy has also been shown to be successful at treating major depressive disorder especially in the last few years where the technique and theory have been refined (1). It has also been demonstrated to be very successful in Malaysian patients (2). In this study we try to show how effective is the treatment when given in combination with SSRI and which SSRI does better in this combination. As far as we know, there has been no such Correspondence Dr. Azhar M. Zain, Professor, Dept. of Psychiatry, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, UPM, Serdang. study in Malaysia to show the comparison of pharmacotherapy and psychotherapy for depression where the psychotherapy is the permanent treatment. This is certainly the first study of its kind in this part of the world. Methodology Sample Subjects selected for the study consisted of male and female patients diagnosed with major depression by a psychiatrist based on DSM IV (3) criteria. The subjects were recruited from among the patients referred by physicians to the psychiatry and psychotherapy clinic of a specialist hospital in Kuala Lumpur. They were then divided at random into three groups, i.e. (1) the escitalopram group (ESC), (2) the sertraline group (STR) and (3) the fluoxetine group (FXT). All groups received cognitive behavior therapy (CBT) as standard treatment. The treatment was carried out over a period of twelve weeks for patients in the FXT group and twelve weeks plus three monthly booster sessions in the ESC and STR groups. The other inclusion criterias 11
2 AZHAR MZ et al. include; age between 18 to 50, ability to communicate well, cooperation to carry out sessions in a group for one hour per week. The exclusion criterias include having other psychiatric disorders besides depression, eg. Neuroses or Axis II traits or disorders. All patients gave informed consent to enter the study. They were dropped from the study if they requested to be included in either group or if the medication needed to be changed or if they missed therapy sessions more than once. The duration of inclusion into the study was from January 2004 until June All together 33 patients were recruited for the STR group, 32 for the ESC group and 31 for the FXT group. Procedure Those in the ESC group received a starting dose of ESC 10 mg. per day. They were seen weekly and the doses were increased as necessary to a maximum of 20 mg./day if no side effects occured. Only two patients needed an increased dose to 20 mg/day. Those in the STR group were treated in a similar manner. They received a starting dose of STR 50 mg. per day. They were seen weekly and the doses were increased as necessary to a maximum of 100 mg/day if no side effects occured. Only three patients needed an increased dose to 100 mg/day. Those in the FXT group received a starting dose of ESC 20 mg. per day. They were seen weekly and the doses were increased as necessary to a maximum of 40 mg/day if no side effects occured. Only two patients needed an increased dose to 40 mg/ day. As mentioned earlier all patients were seen for weekly sessions of CBT but were never given any NFD or any other drugs. All patients were seen weekly for 12 weeks and those in the last first two groups received weekly sessions of CBT for 12 weeks with addition of 3 booster sessions monthly. At weekly meetings and at baseline, a research assistant who was blind to the patients group measured the following tests. The tests were a) the Hamilton Depression Scale (HDS) (4), b) the Beck Depression Inventory (BDI) (5), c) the World Health Organization Quality of Life Scale-Brief Version (WHOQOL-BREF) (6). (This was measured only at baseline and at 12 weeks) Analysis The results of all the tests from the three groups of patients were analyzed statistically using chi square, t test, and Anova.. Results The study was conducted over a period of three and a half years. Altogether each patient could be analyzed after receiving treatment for 12 weeks initially and 6 months after start of treatment for some patients. There were all together 96 patients with 32 patients in the ESC group, 33 in the STR group and 31 in the FXT group. The results are shown in the tables below. Table 1 shows that there was no difference in age between the three groups. There was also no significant difference in baseline measurements of BDI, BAI and QOL between the three groups. However after 12 weeks there was a significant difference in all measurements. All patients improved significantly but patients in the ESC group improved better than those in the other two groups. The QOL score also improved in all groups but there was more marked improvement in the ESC group compared with the other two groups. Table 2 shows the results of the analysis done for the first two groups after 6 months of treatment. There was a significant change in both groups at the end of two months however at the end of 6 months there was no significant difference between the two groups. It was obvious that both groups responded well to treatment but the ESC group showed better improvement at two months while both showed similar improvement at 6 months. The results seemed to indicate that those in the ESC group responded faster than in the STR group. Discussion There are specific measuring tools to measure depression. The BDI and HDS were chosen because they are self-administered, not too time consuming, easy to use by patients and the patients were given CBT, which uses these measurements as part of the therapy recording. Patients with this disorder also tend to have a low level of quality of life. We thought this measure would be useful to assess overall improvements in patients. It is very difficult to measure quality of life because there are numerous scales available but no one scale is comprehensive enough to measure all the aspects we would like to look at. The most easy to use in our patients seem to be the WHOQOL-BREF as it has only 30 questions and takes a short time to administer and is not difficult for the patients to understand. It also covers rather comprehensively most of the domains we would like to measure. 12
3 COMPARISON OF DIFFERENT ANTIDEPRESSANTS AND PSYCHOTHERAPY IN THE SHORT-TERM TREATMENT OF DEPRESSION The findings of significant reduction in practically all measures in all groups were expected as they were all being given standard treatment. Using Anova it was clear that the patients in the ESC group did best while the STR group was second and FXT group third, but all three methods were beneficial for all patients. This could be explained by the anxiety and cognitive symptoms present in these patients. If we assume that depression has a lot of psychological component although it is a biological disorder. The psychological symptoms could be maintained by biological factors and as such the results fit the model. So if psychological treatment is used to treat the core issue of the disorder then the other symptoms which are secondary will improve along of course with the help of drugs. Based on Beck s model of depression (7) the negative thoughts and thinking errors were corrected in all patients. It seems that patients in ESC group responded faster perhaps due to their ability to concentrate better or faster than the other two groups. This could be the result of inherent factors within the drug or reduced side effect profile which we are not able to establish because these issues were not measured. However it would be a good project to look at in the future. The measure of QOL was probably the best measure to look at comparing between the groups as it is the end result that would like to establish at the end of treatment i.e. not just reduction in scores of depression but also increase in QOL scores to indicate actual return to normal life. The ESC group again had the highest score and the highest incremental change in QOL compared to the other two groups. As such again the reason for this could be the faster response of patients to the medication or lowered side effects or other reasons to be discovered. We can only postulate but the obvious message from this study is that patients will respond well and quickly to a combination of psychotherapy and an effective antidepressant and will maintain the response for at least 6 months if booster therapy sessions are conducted together with continued usage of medication. All results seem to favour a combination use of drugs together with psychological treatment. But not all doctors would like to do psychological treatment or is comfortable with its techniques. It can be time consuming and patients may not stay in treatment. So how can we make use of the results of this study? At the present time based on referrals, our experience tells us that in Malaysia the majority of family physicians and general practitioners use a SSRI to treat depressive disorders. These are very good drugs which help to calm the patient and has a reasonably fast onset of action however no CBT is given to these patients. It might be useful to refer the cases for CBT in those that do not respond after a few weeks. Otherwise they could use the result of this study to select the best SSRI for their patients. It is important for clinicians to understand that depressive disorder can severely affect the daily life of sufferers. It is well known that suicide rates in depression can reach a rate of 20% or higher (8). As such this condition must be aggressively treated. As most patients see their family physicians or general practitioners initially it is highly important that the family doctor makes the right diagnosis and institutes the right treatment. As can be seen from the results, the SSRIs have significant positive results on the patients. However the improvement were shown after 12 weeks of treatment. It is therefore very important for family physicians (FP) to be patient when using this drug. Several studies have indicated that CBT + SSRIs are useful or better than CBT alone in treating anxiety (9, 10). As such the FP should attempt to use antidepressants especially SSRI in the treatment of major depression. Its efficacy has been proven by many studies over time. The only drawback is that it takes time to work. Patients with depression have been shown to be particularly sensitive to physical symptoms and medication effects (11). The serotonin reuptake inhibitors (SSRIs) have an improved tolerability over the traditional tricyclics and most side effects resolve over time and safety in the medically ill and with overdoses have been established (12). Depression is also not an acute condition but is really a chronic and recurring condition requiring long-term management. As such an SSRI is more acceptable. Treatment should ideally combine psychological treatment with SSRI. Concomitant use of a benzodiazepine if no psychological treatment is used may be helpful but the duration of use should not exceed 2 to 3 weeks. The dose that makes the patient recover should be continued for at least one to two years although studies are still being conducted to ascertain this. If symptoms persist then the obvious thing is to continue treatment or to add psychological treatment. It is not uncommon for FP to conduct psychological treatment. Studies in United Kingdom and Germany (13, 14) have shown that FP can be trained and have shown remarkable results using CBT in depressive patients. In Malaysia most patients also have somatic complaints and these are the initial complaints that take 13
4 AZHAR MZ et al. them to see FPs or GPs There have been several models described but the one the author is most used to is the one by Paul Salkovskis (15). Central in the CBT conceptualization of somatic symptoms is the way patients think about bodily sensations. Beliefs that patient have about the nature of their symptoms can result in a confirmatory bias with respect to illnessrelated information. As a result, such patients selectively notice and remember information that is consistent with their beliefs about their problems. If benign bodily sensations are regarded as being symptomatic of disease, several consequences ensue. First, patients will experience emotional distress, which may cause further bodily sensations. Second, increased attention will be paid to these sensations. Third, the type of behaviours adopted to cope with the symptoms may be dysfunctional in that they act to exacerbate the problem rather than relieve it. Fourth, other people including doctors may respond to patients in a way that intensifies, rather than reduces their concern with disease, attention to bodily sensations and dysfunctional coping. All these processes may become linked in selfperpetuating vicious circles. Patients with somatic symptoms commonly believe that their symptoms have a physical cause. Functional somatic symptoms have been found to be associated with both anxiety and depression which are consequences of the dread or false beliefs of having a disease. Thus with an understanding of this hypothesis, the doctor can modify his/her therapy technique to treat these patients. Using actual CBT techniques will obviously be difficult but counseling using CBT hypothesis might suffice in most patients while the more resistant ones can be sent for further management to a psychiatrist or psychotherapist. Besides the CBT model for depression is very easy to grasp and can be used to treat all patients since depression is the Table 1 : Treatment types received by patients and the results of BDI, BAI, and QOL at baseline and at end of 12 weeks. Treatment Age BDI BDI BAI BAI QOL QOL types Mean pre 12 Pre 12 Pre 12 (sd) Rx sess Rx sess Rx sess CBT + ESC (6.25) (2.15) (2.89) (2.7) (3.97) (3.78) (2.91) CBT + STR (6.17) (3.26) (3.86) (2.36) (4.22) (4.11) (4.32) CBT + FXT (6.76) (1.89) (2.54) (2.3) (1.95) (4.16) (3.63) BDI ; Beck Depression Inventory BAI ; Beck Anxiety Inventory QOL; WHO Quality of life Brief Version Scale Table 2 : Treatment types received by patients and the results of HDS at baseline, at end of 12 weeks and at the end of 6 months. Treatment type Total patients HDS mean HDS mean HDS mean 2 weeks 12 weeks 6 months CBT + ESC CBT + STR NS P<0.001 NS HDS ; Hamilton Depression Scale NS ; Not significant 14
5 COMPARISON OF DIFFERENT ANTIDEPRESSANTS AND PSYCHOTHERAPY IN THE SHORT-TERM TREATMENT OF DEPRESSION main symptom present in the patients. Also when used in combination, the dose of the drug can be reduced and thereby reduce the possibility of side effects which could further aggravate the misinterpretation beliefs patients hold regarding their health. References 1. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression, Guilford Press, New York Azhar MZ. Cognitive Psychotherapy Experience with Kelantan Clients. Medical J. of Malaysia 1998; 53(2): APA. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders- Revised (4th. Edition), Washington D.C., APA, Hamilton M. A Rating Scale for Depression. Journal of Neurology, Neurosurgery and Psychiatry 1960; 23: Beck AT, Ward CH, Mendelson M et al. An Inventory for Measuring Depression. Archives of General Psychiatry 1961;4: The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychological Medicine 1988; 28: Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression, Guilford Press, New York Rihmer Z. Suicide Risks in Mood Disorders. Curr Opin Psychiatry 2007; 20(1): Sharp EA. Comparison of Fluvoxamine and CBT and Placebo in Panic Disorder, Psychological Medicine 1996; 53: Azhar MZ. Comparison of Fluvoxamine Alone, Fluvoxamine and Cognitive Psychotherapy and Psychotherapy Alone in the Treatment of Panic Disorderin Kelantan Implications for Management by Family Doctors. Med. J. Malaysia 2000; 55(4): Jones LR, Mabe III, Riley WT. Illness Coping Strategies and Hypochondriacal Traits among Medical Inpatients. Int. J. of Psychiat. in Med. 1989; 19: Fontaine R, Ontiveros A, Elie R et al. A Double- Blind Comparison of Nefazodone, Imipramine, and Placebo in Major Depression. J. Clin. Psychiatry 1994; 55(6): Linden M. Cognitive Behaviour Therapy under Conditions of Routine Treatment in the General Health Care System. Behav. & Cog. Psychotherapy 1996; 24: Scott CS, Scott JL, Tacchi MJ, et al. Abbreviated Cognitive Therapy for Depression: A Pilot Study in Primary Care. Behav. & Cog. Psychotherapy 1994; 22: Salkovskis PM. Somatic Problems. In KE Hawton, PM Salkovskis, J Kirk and DM Clark (Eds.) Cognitive Behaviour Therapy for Psychiatric Problems: A Practical Guide, Oxford: Oxford University Press,
ORIGINAL ARTICLE. M Z Azhar, M.P.M., Psychotherapy Clinic, Hospital Universiti Sains Malaysia, Kubang Kerian, Kota Bahru, Ke1antan.
Comparison of Fluvoxamine Alone, Fluvoxamine and Cognitive Psychotherapy and Psychotherapy Alone in tile Treatment of Panic Disorder In Kelantan Implications for Management by Family Doctors M Z Azhar,
More informationC nitive Psychotherapy Experience with
C nitive Psychotherapy Experience with Kelantan Clients M Z Azhar, MPM, Psychotherapy Clinic, USM Hospital, Kubang Kerian, 16150 Kota Bham, Kelantan introduction The mode and duration of psychotherapy
More informationMetacognitive therapy for generalized anxiety disorder: An open trial
Journal of Behavior Therapy and Experimental Psychiatry 37 (2006) 206 212 www.elsevier.com/locate/jbtep Metacognitive therapy for generalized anxiety disorder: An open trial Adrian Wells a,, Paul King
More informationAre psychological treatments of panic disorder efficacious?
Are psychological treatments of panic disorder efficacious? Peter Wilhelm 7.3.2018 PD Dr. Peter Wilhelm, Spring 2018 1 Efficacy of Behavioral Treatment of Panic Disorder First randomised controlled trial
More informationSUPPORTING COLLABORATIVE CARE THROUGH MENTAL HEALTH GROUPS IN PRIMARY CARE Hamilton Family Health Team
SUPPORTING COLLABORATIVE CARE THROUGH MENTAL HEALTH GROUPS IN PRIMARY CARE Hamilton Family Health Team Jackie Bootsma, MSW, RSW Marian Schorr, MSW, RSW About Family Health Teams Family Health Teams are
More informationObsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care
Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,
More informationAnxiety Disorders: First aid and when to refer on
Anxiety Disorders: First aid and when to refer on Presenter: Dr Roger Singh, Consultant Psychiatrist, ABT service, Hillingdon Educational resources from NICE, 2011 NICE clinical guideline 113 What is anxiety?
More informationKEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.
KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised
More informationTaking Care: Child and Youth Mental Health TREATMENT OPTIONS
Taking Care: Child and Youth Mental Health TREATMENT OPTIONS Open Learning Agency 2004 TREATMENT OPTIONS With appropriate treatment, more than 80% of people with depression get full relief from their symptoms
More informationReview Article A Review on Assessment and Treatment for Depression in Malaysia
Hindawi Publishing Corporation Research and Treatment Volume 2011, Article ID 123642, 8 pages doi:10.1155/2011/123642 Review Article A Review on Assessment and Treatment for in Malaysia Firdaus Mukhtar
More informationGuidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive
More informationProceedings of the International Conference on RISK MANAGEMENT, ASSESSMENT and MITIGATION
COGNITIVE-BEHAVIOURAL THERAPY EFFICACY IN MAJOR DEPRESSION WITH ASSOCIATED AXIS II RISK FACTOR FOR NEGATIVE PROGNOSIS DANIEL VASILE*, OCTAVIAN VASILIU** *UMF Carol Davila Bucharest, ** Universitary Military
More informationMeasurement-based Scales in Major Depressive Disorder:
This program is paid for by Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck, LLC. The speaker is a paid contractor of Otsuka Pharmaceutical Development and Commercialization, Inc.
More informationCBT for Hypochondriasis
CBT for Hypochondriasis Ahmad Alsaleh, MD, FRCPC Assistant Professor of Psychiatry College of Medicine, KSAU-HS, Jeddah Agenda Types of Somatoform Disorders Characteristics of Hypochondriasis Basic concepts
More informationCognitive Therapy Of Depression By Aaron T. Beck, etc.
Cognitive Therapy Of Depression By Aaron T. Beck, etc. Cognitive behavioral therapy Beck called it cognitive therapy because of the importance it places on thinking. Bipolar or Depression? 84 American
More informationGuilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.
1-800-PSYCH If you are obsessive-compulsive, dial 1 repeatedly If you are paranoid-delusional, dial 2 and wait, your call is being traced If you are schizophrenic, a little voice will tell you what number
More informationModule 4: Case Conceptualization and Treatment Planning
Module 4: Case Conceptualization and Treatment Planning Objectives To better understand the role of case conceptualization in cognitive-behavioral therapy. To develop specific case conceptualization skills,
More informationSummary of guideline for the. treatment of depression RANZCP CLINICAL PRACTICE GUIDELINES ASSESSMENT
RANZCP CLINICAL PRACTICE GUIDELINES Summary of guideline for the RANZCP CLINICAL PRACTICE GUIDELINES treatment of depression Pete M. Ellis, Ian B. Hickie and Don A. R. Smith for the RANZCP Clinical Practice
More informationAcute Stabilization In A Trauma Program: A Pilot Study. Colin A. Ross, MD. Sean Burns, MA, LLP
In Press, Psychological Trauma Acute Stabilization In A Trauma Program: A Pilot Study Colin A. Ross, MD Sean Burns, MA, LLP Address correspondence to: Colin A. Ross, MD, 1701 Gateway, Suite 349, Richardson,
More information11. Psychopharmacological Intervention
11. Psychopharmacological Intervention 11.1 Goals of Psychopharmacology The goal of psychopharmacology is to ensure that patients with more severe forms of depression and those who fail to benefit adequately
More informationTreating Depression in Disadvantaged Women: What is the evidence?
Treating Depression in Disadvantaged Women: What is the evidence? Megan Dwight Johnson, MD MPH Associate Professor Medical Director, UWMC Inpatient Psychiatry Department of Psychiatry and Behavioral Sciences
More informationGuideline for the Diagnosis and Management of Generalized Anxiety Disorder for Primary Care Physicians
MAGELLAN BEHAVIORAL HEALTH/ BLUE CROSS BLUE SHIELD OF NORTH CAROLINA Guideline for the Diagnosis and Management of Generalized Anxiety Disorder for Primary Care Physicians This guideline includes recommendations
More informationDiabetes and Depression. Roshini Pinto-Powell, MD Stephen Noyes, LICSW, LADC William Gunn, PhD Beverly Bean, RN, C
Diabetes and Depression Roshini Pinto-Powell, MD Stephen Noyes, LICSW, LADC William Gunn, PhD Beverly Bean, RN, C 2008 Learning Objectives State the risk factors for depression Identify the vulnerability
More informationJonathan Haverkampf PANIC ATTACKS PANIC ATTACKS. Christian Jonathan Haverkampf MD
Christian MD Panic attacks can be highly debilitating as they occur spontaneously and come with a dread of impending doom and often death. Their unpredictability and the strong feelings of anxiety can
More informationSTRESS CONTROL LARGE GROUP THERAPY FOR GENERALIZED ANXIETY DISORDER: TWO YEAR FOLLOW-UP
Behavioural and Cognitive Psychotherapy, 1998, 26, 237 245 Cambridge University Press. Printed in the United Kingdom STRESS CONTROL LARGE GROUP THERAPY FOR GENERALIZED ANXIETY DISORDER: TWO YEAR FOLLOW-UP
More informationBeck Depression Inventory Minimum Important Difference. Robert D. Kerns, Ph.D. Yale University VA Connecticut Healthcare System
Beck Depression Inventory Minimum Important Difference Robert D. Kerns, Ph.D. Yale University VA Connecticut Healthcare System Beck Depression Inventory Beck, A.T., Ward, C.H., Mendelson, M., Mock, J.,
More informationApplication of Psychotropic Drugs in Primary Care
Psychotropic Drugs Application of Psychotropic Drugs in Primary Care JMAJ 47(6): 253 258, 2004 Naoshi HORIKAWA Professor, Department of Psychiatry, Tokyo Women s Medical University Abstract: The incidence
More informationAre psychological treatments of panic disorder efficacious?
Are psychological treatments of panic disorder efficacious? Peter Wilhelm 7.3 and 14.3.2018 PD Dr. Peter Wilhelm, Spring 2018 1 Efficacy of Behavioral Treatment of Panic Disorder First randomised controlled
More informationDr.Rahiminejad Roozbeh Hospital TUMS
Dr.Rahiminejad Roozbeh Hospital TUMS Psychiatric disorders, particularly depression, anxiety and eating disorders, are prevalent in diabetes. Mental illness increases risk of diabetes and diabetic complications.
More informationHypochondriasis Is it an Anxiety Disorder? Health Anxiety Disorder
Hypochondriasis Is it an Anxiety Disorder? Health Anxiety Disorder Steve Ellen MB, BS, M.Med, MD, FRANZCP Head, Consultation, Liaison & Emergency Psychiatry, Alfred Health. Associate Professor, School
More informationAntidepressant does not relieve repetitive behaviors
NEWS Antidepressant does not relieve repetitive behaviors BY KELLY RAE CHI 16 JUNE 2009 1 / 5 Bitter pill: Negative results from clinical trials of two antidepressants, Celexa and Prozac, challenge the
More informationIs Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A
Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College
More informationOCD Service: Back to Clinical Practice. August 7, 2015
OCD Service: Back to Clinical Practice August 7, 2015 Pichaya Kusalaruk, Ratana Saipanish, Thanita Hiranyatheb First line treatment t t for OCD Selective serotonin reuptake inhibitors (SSRIs) Cognitive
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationAnxiety disorders part II
Anxiety disorders part II OBSESSIVE-COMPULSIVE DISORDER obsession a recurrent and intrusive thought, feeling, idea, or sensation compulsion a conscious, standarized, recurring pattern of behavior, such
More informationChildren s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
More informationReviewing the long-term use of selective serotonin reuptake inhibitors in patients with depression
CLINICAL AUDIT Reviewing the long-term use of selective serotonin reuptake inhibitors in patients with depression Valid to November 2022 bpac nz better medicin e Audit Focus This audit helps health professionals
More informationTianeptine Dependence: A Case Report
CASE REPORT Tianeptine Dependence: A Case Report Syed Nabil, Ng Chong Guan, Rusdi Abd Rashid Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia Abstract
More informationCognitive Behavioural Psychotherapy for Anxiety Disorders MODULE CODE LEVEL 7 CREDITS 15 ECTS CREDITS VALUE FACULTY
MODULE DESCRIPTOR TITLE Cognitive Behavioural Psychotherapy for Anxiety Disorders MODULE CODE 66-700641 LEVEL 7 CREDITS 15 ECTS CREDITS VALUE FACULTY HWB DEPARTMENT Nursing & Midwifery SUBJECT GROUP DATE
More informationIntensive Treatment Program Interview with Dr. Eric Storch of The University of South Florida OCD Program in St. Petersburg, Florida January 2009
Intensive Treatment Program Interview with Dr. Eric Storch of The University of South Florida OCD Program in St. Petersburg, Florida January 2009 1. When did you open your program? Our program is relatively
More informationAnxiety Disorders. Fear & Anxiety. Anxiety Disorder? 26/5/2014. J. H. Atkinson, M.D. Fear. Anxiety. An anxiety disorder is present when
Anxiety s J. H. Atkinson, M.D. HIV Neurobehavioral Research Center University of California, San Diego Department of Psychiatry & Veterans Affairs Healthcare System, San Diego Materials courtesy of Dr.
More informationThe Current Status of Treatment for Anorexia Nervosa and Bulimia Nervosa
The Current Status of Treatment for Anorexia Nervosa and Bulimia Nervosa David B. Herzog Martin B. Keller Michael Strober Christine Yeh Sung-Yun Pai (Accepted 1 March 1991) A survey investigating the current
More informationBrief Cognitive Therapy for Panic Disorder A Randomized Controlled Trial
Page 1 of 10 Journal of Consulting and Clinical Psychology August 1999 Vol. 67, No. 4, 583-589 1999 by the American Psychological Association For personal use only--not for distribution. Brief Cognitive
More informationAntidepressants (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors) in children 6-12 years of age with depressive episode/disorder
updated 2012 Antidepressants (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors) in children 6-12 years of age with depressive episode/disorder Q10: Are antidepressants (Tricyclic antidepressants
More informationPharmacological treatment of anxiety disorders where is
Pharmacological treatment of anxiety disorders where is the room for improvement? David S Baldwin, Professor of Psychiatry BAP Masterclass, 15 th April 2011 dsb1@soton.ac.uk Declaration of interests (last
More informationfor anxious and avoidant behaviors.
Summary of the Literature on the Treatment of Anxiety Disorders in Children and Adolescents Sucheta D. Connolly, M.D.* Non-OCD anxiety disorders in youth are common and disabling, with 12-month prevalence
More informationAppendix 15c: Study characteristics - high-intensity psychological interventions and combination therapies
Appendix 15c: Study characteristics - high-intensity psychological interventions and combination therapies In the treatment of GAD, what are the risks and benefits associated with high-intensity psychological
More informationImplementing Dialectical Behaviour Therapy (DBT) Skills training on a male low secure ward
Implementing Dialectical Behaviour Therapy (DBT) Skills training on a male low secure ward Dr Louise Roberts (Lead Clinical Psychologist) Viktoria Nagy (Assistant Psychologist) Robin Pinto Unit 12.06.2018
More informationSupplemental Digital Content
PharmacoEconomics Do Productivity Costs Matter? The Impact of Including Productivity Costs on the Cost Effectiveness of Interventions Targeted at Depressive Disorders Krol M, et al. Supplemental Digital
More informationII3B GD2 Depression and Suicidality in Human Research
Office of Human Research Protection University of Nevada, Reno II3B GD2 Depression and Suicidality in Human Research Overview Research studies that include measures for depression and suicidality should
More informationAdult Mental Health Services applicable to Members in the State of Connecticut subject to state law SB1160
Adult Mental Health Services Comparison Create and maintain a document in an easily accessible location on such health carrier's Internet web site that (i) (ii) compares each aspect of such clinical review
More informationThis is because the situation is demystified and the element of fear of the unknown is eliminated.
This is more or less along the lines of the strategies we have already discussed for stress. These include common sense measures such as engaging in healthy lifestyle activities: exercising, eating well,
More informationU.S. 1 February 22, 2013
U.S. 1 February 22, 2013 A Placebo-controlled, Randomized, Blinded, Dose Finding Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults Study Code: MAA-1 Sponsor: Multidisciplinary
More informationExposure Therapy. in Low Intensity CBT. Marie Chellingsworth, Dr Paul Farrand & Gemma Wilson. Marie Chellingsworth, Dr Paul Farrand & Gemma Wilson
Exposure Therapy in Low Intensity CBT Marie Chellingsworth, Dr Paul Farrand & Gemma Wilson CONTENTS Part 1 What is Exposure Therapy? Exposure Therapy Stages Part 2 Doing Exposure Therapy The Four Rules
More informationPatients in the MIDAS Project. Exclusion Due to Bipolarity or Psychosis. Results
Things You Think You Know Things You Think You Know, That May Not Be True in the Diagnosis and Treatment of Depression Mark Zimmerman, MD Director of Outpatient Psychiatry Director of the Partial Hospital
More informationIs Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A
Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College
More informationCognitive-Behavioral Assessment of Depression: Clinical Validation of the Automatic Thoughts Questionnaire
Journal of Consulting and Clinical Psychology 1983, Vol. 51, No. 5, 721-725 Copyright 1983 by the American Psychological Association, Inc. Cognitive-Behavioral Assessment of Depression: Clinical Validation
More informationMy name is Jennifer Gibbins-Muir and I graduated from the Factor-Inwentash Faculty of Social Work in 2001.
Profiles in Social Work Episode 12 Jennifer Gibbins-Muir Intro - Hi, I m Charmaine Williams, Associate Professor and Associate Dean, Academic, for the University of Toronto, Factor-Inwentash Faculty of
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationDealing with Feelings: The Effectiveness of Cognitive Behavioural Group Treatment for Women in Secure Settings
Behavioural and Cognitive Psychotherapy, 2011, 39, 243 247 First published online 30 November 2010 doi:10.1017/s1352465810000573 Dealing with Feelings: The Effectiveness of Cognitive Behavioural Group
More informationSEIZURES AND DEPRESSION
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences SEIZURES AND DEPRESSION JENNIFER M. ERICKSON, DO PSYCHIATRY CONSULT AND TELEPSYCHIATRY DEPARTMENT OF PSYCHIATRY
More informationPsychological therapies for people with dementia who have associated depression [New 2015].
Psychological therapies for people with dementia who have associated depression [New 2015]. SCOPING QUESTION: For people with dementia and comorbid depression, do psychological interventions (including
More informationClinical Guideline for the Management of Bipolar Disorder in Adults
Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:
More informationLet s Talk About Treatment
What Doesn t Work Let s Talk About Treatment Lisa R. Terry, LPC What we ve tried Talk therapy- You can t talk you way out of a medical disorder Play Therapy Family Therapy Psychoanalysis While these are
More informationDepression in adults: treatment and management
1 2 3 4 Depression in adults: treatment and management 5 6 7 8 Appendix V3: recommendations that have been deleted of changed from 2009 guideline Depression in adults: Appendix V3 1 of 22 1 Recommendations
More informationIntroduction into Psychiatric Disorders. Dr Jon Spear- Psychiatrist
Introduction into Psychiatric Disorders Dr Jon Spear- Psychiatrist Content Stress Major depressive disorder Adjustment disorder Generalised anxiety disorder Post traumatic stress disorder Borderline personality
More informationTrichotillomania: A Case Study
The International Journal of Indian Psychology ISSN 2348-5396 (e) ISSN: 2349-3429 (p) Volume 5, Issue 1, DIP: 18.01.060/20170501 DOI: 10.25215/0501.060 http://www.ijip.in October-December, 2017 Case Study
More informationOxleas CAMHS Dr Joanna Sales Clinical Director. Adolescent problems: Depression Deliberate Self Harm Early Intervention in Psychosis
Oxleas CAMHS Dr Joanna Sales Clinical Director Adolescent problems: Depression Deliberate Self Harm Early Intervention in Psychosis PREVALENCE At any one time, the estimated number of children and young
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Age as factor in selective mutism, 623 as factor in social phobia, 623 Agoraphobia, 593 600 described, 594 596 DSM-V changes related to,
More informationDocument Title Pharmacological Management of Generalised Anxiety Disorder
Document Title Pharmacological Management of Generalised Anxiety Disorder Document Description Document Type Policy Service Application Trust Wide Version 1.1 Policy Reference no. POL 201 Lead Author(s)
More informationLecture Outline Signs and symptoms in psychiatry Adjustment Disorders Other conditions that may be a focus of clinical attention
V Codes & Adjustment Disorders Cornelia Pinnell, Ph.D. Argosy University/Phoenix Lecture Outline Signs and symptoms in psychiatry Adjustment Disorders Other conditions that may be a focus of clinical attention
More informationMICHAEL PRITCHARD. most of the high figures for psychiatric morbidity. assuming that a diagnosis of psychiatric disorder has
Postgraduate Medical Journal (November 1972) 48, 645-651. Who sees a psychiatrist? A study of factors related to psychiatric referral in the general hospital Summary A retrospective study was made of all
More informationMajor Depressive Disorder (MDD) in Children under Age 6
in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 6. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian
More informationNeuropathophysiologyof
Neuropathophysiologyof Epilepsy and Psychiatric Comorbidity & Diagnosis and Management of Non- Epileptic Attack Disorders N Child Neurologist Auckland City Hospital Psychiatric Disorders associated with
More informationOutline. Understanding Placebo Response in Psychiatry: The Good, The Bad, and The Ugly. Definitions
Outline Understanding Placebo Response in Psychiatry: The Good, The Bad, and The Ugly Michael E. Thase, MD Professor of Psychiatry Perelman School of Medicine University of Pennsylvania and Philadelphia
More informationCH 4: Antidepressants among adolescents with moderate-severe depressive disorder for whom psychosocial interventions have proven ineffective.
CH 4: Antidepressants among adolescents with moderate-severe depressive disorder for whom psychosocial interventions have proven ineffective. SCOPING QUESTION: Are antidepressants (specifically, tricyclic
More informationMEDICATION ALGORITHM FOR ANXIETY DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences MEDICATION ALGORITHM FOR ANXIETY DISORDERS RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UNIVERSITY OF WASHINGTON
More informationStandard 5F. Psychotherapy
The Basics of CBT with Children and Adolescents The presenters have no financial disclosures to report. Pamela Lusk, DNP, RN, PMHNP-BC,FAANP Bernadette Melnyk, PhD, RN, PMHNP-BC, / CPNP, FNAP, FAANP, FAAN
More informationPSYCHOTROPIC MEDICATION AND THE WORKPLACE. Dr. Marty Ewer 295 Fullarton Road Parkside
PSYCHOTROPIC MEDICATION AND THE WORKPLACE Dr. Marty Ewer 295 Fullarton Road Parkside 5063 82999281 Introduction Depression and anxiety commonly occur in people who work. The World Health Organization has
More informationScientific background for the EDOR-Test
FROM DISCOVERY TO CLINICAL ROUTINE The Journey for EDOR started with a small, blind study in the mid-eighties and has since then gained more evidence as a method for detecting hyporeactivity as a risk
More informationSuicide Risk and Melancholic Features of Major Depressive Disorder: A Diagnostic Imperative
Suicide Risk and Melancholic Features of Major Depressive Disorder: A Diagnostic Imperative Robert I. Simon, M.D.* Suicide risk is increased in patients with Major Depressive Disorder with Melancholic
More informationDepression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
More informationEffective Treatment of Depression in Older African Americans: Overcoming Barriers
Effective Treatment of Depression in Older African Americans: Overcoming Barriers R U T H S H I M, M D, M P H A S S I S T A N T P R O F E S S O R, D E P A R T M E N T O F P S Y C H I A T R Y A N D B E
More informationDEPRESSION. Dr. Jonathan Haverkampf, M.D.
Dr., M.D. Depression is one of the most common medical conditions, which can interfere with a person s quality of life, relationships and ability to work significantly. Fortunately, there are a number
More informationDiagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD
Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty
More informationTITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder.
Brief Summary TITLE: Practice parameters for the assessment and treatment of children and adolescents with posttraumatic stress disorder. SOURCE(S): Practice parameters for the assessment and treatment
More informationThe Detection and Treatment of Perinatal Depression in Medical Settings
The Detection and Treatment of Perinatal Depression in Medical Settings Ryan J Van Lieshout, MD, PhD, FRCP(C) Albert Einstein/Irving Zucker Chair in Neuroscience Assistant Professor, Department of Psychiatry
More information5 COMMON QUESTIONS WHEN TREATING DEPRESSION
5 COMMON QUESTIONS WHEN TREATING DEPRESSION Do Antidepressants Increase the Possibility of Suicide? Will I Accidentally Induce Mania if I Prescribe an SSRI? Are Depression Medications Safe and Effective
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice
More informationADHD clinic for adults Feedback on services for attention deficit hyperactivity disorder
ADHD clinic for adults Feedback on services for attention deficit hyperactivity disorder Healthwatch Islington Healthwatch Islington is an independent organisation led by volunteers from the local community.
More informationANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT GURMEET SINGH 1 R. K. SHARMA 2 SUMMARY
Indian Journal of Psychiatry, January 29(1), pp 49-56 ANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT GURMEET SINGH 1 R. K. SHARMA 2 SUMMARY A total of 90 patients
More informationComorbidity of Depression and Other Diseases
Comorbidity of Depression and Other Diseases JMAJ 44(5): 225 229, 2001 Masaru MIMURA Associate Professor, Department of Psychiatry, Showa University, School of Medicine Abstract: This paper outlines the
More informationDEPARTMENT OF PSYCHIATRY. Newsletter
DEPARTMENT OF PSYCHIATRY Office of the Chair - Week of April 15-19, 2013 Website: http://www.hsc.usf.edu/psych/ Newsletter Meetings Thursday 04/18/13 8:00 a.m. Call Center Meeting Resident Lectures: 8:00
More informationDon t be fooled by hypochondria WORKING AS A TEAM Ideal approach. Suzanne B. Feinstein, PhD Brian A. Fallon, MD, MPH
Don t be fooled by hypochondria Diagnostic checklist helps rule out psychiatric and medical disorders and avoid treatment errors A hypochondria checklist can help you sort through many overlapping medical
More informationPharmacists in Medication Adherence in Psychiatric Patients
Pharmacists in Medication Adherence in Psychiatric Patients Mamta Parikh, PharmD, BCPS, BCPP Assistant Professor, Clinical and Administrative Sciences Notre Dame of Maryland University School of Pharmacy
More informationA questionnaire to help general practitioners plan cognitive behaviour therapy
Primary Care Mental Health 2006;4:00 00 # 2006 Radcliffe Publishing Research paper A questionnaire to help general practitioners plan cognitive behaviour therapy MS Vassiliadou Eginiton Hospital, Athens,
More informationTreatment Quad Cities Eating Disorders Consortium
Treatment Quad Cities Eating Disorders Consortium James E. Mitchell, MD UND School of Medicine and Health Sciences Neuropsychiatric Research Institute ANOREXIA NERVOSA BULIMIA NERVOSA BINGE EATING DISORDER
More informationthe Worry Over Anxiety Disorders in All the Wrong Places How do you detect anxiety disorders? In this article: By Sagar V.
Focus on the University of Toronto Ending Title in All the Wrong Places the Worry Over Anxiety Disorders By Sagar V. Parikh, MD, FRCPC In this article: 1. How do you detect anxiety disorders? 2. What is
More informationComparison of Depression Interventions after Acute Coronary Syndrome
Comparison of Depression Interventions after Acute Coronary Syndrome Funded by the National Heart Lung and Blood Institute RC2-HL HL-101663 Depressive Symptoms are Related to Acute Coronary Events Increased
More informationPTSD: Treatment Opportunities
PTSD: Treatment Opportunities Professor Malcolm Hopwood Department of Psychiatry University of Melbourne Professorial Psychiatry Unit, Albert Road Clinic DSM 5: PTSD CRITERION A exposure to: actual or
More information